Purple Biotech Ltd (TLV:PPBT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3.800
+0.100 (2.70%)
Aug 14, 2025, 11:49 AM IDT
-73.05%
Market Cap 22.43M
Revenue (ttm) n/a
Net Income (ttm) -8.80M
Shares Out 606.09M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,000
Average Volume 1,754,179
Open 3.700
Previous Close 3.700
Day's Range 3.700 - 3.800
52-Week Range 3.400 - 21.000
Beta -0.58
RSI 42.63
Earnings Date Aug 4, 2025

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 9
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PPBT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.